Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 91 articles: HTML format

Single Articles

May 2008
1. MCDERMOTT U , Iafrate AJ, Gray NS, Shioda T, et al
   Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.
   Cancer Res. 2008;68:3389-95.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. LI B , Shi S, Qian W, Zhao L, et al
   Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.
   Cancer Res. 2008;68:2400-8.
   PubMed     Related articles    Abstract available
   
   
   March 2008
3. RAMALINGAM A , Duhadaway JB, Sutanto-Ward E, Wang Y, et al
   Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.
   Cancer Res. 2008;68:1683-90.
   PubMed     Related articles    Abstract available
   
   
   
4. ANEJA R , Liu M, Yates C, Gao J, et al
   Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.
   Cancer Res. 2008;68:1495-503.
   PubMed     Related articles    Abstract available
   
   
   
5. XIA T , O'Hara A, Araujo I, Barreto J, et al
   EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.
   Cancer Res. 2008;68:1436-42.
   PubMed     Related articles    Abstract available
   
   
   
6. TAN Y , Timakhov RA, Rao M, Altomare DA, et al
   A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.
   Cancer Res. 2008;68:1296-302.
   PubMed     Related articles    Abstract available
   
   
   February 2008
7. MARZEC M , Halasa K, Kasprzycka M, Wysocka M, et al
   Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
   Cancer Res. 2008;68:1083-91.
   PubMed     Related articles    Abstract available
   
   
   
8. LINDEMANN RK
   Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma.
   Cancer Res. 2008;68:961-4.
   PubMed     Related articles    Abstract available
   
   
   
9. CRIPPA L , Gasparri A, Sacchi A, Ferrero E, et al
   Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
   Cancer Res. 2008;68:1154-61.
   PubMed     Related articles    Abstract available
   
   
   
10. KOBAYASHI H , Nagato T, Takahara M, Sato K, et al
    Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Cancer Res. 2008;68:901-8.
    PubMed     Related articles    Abstract available
    
    
    
11. WANG D , Long J, Dai F, Liang M, et al
    BCL6 represses Smad signaling in transforming growth factor-beta resistance.
    Cancer Res. 2008;68:783-9.
    PubMed     Related articles    Abstract available
    
    
    January 2008
12. BREMER E , ten Cate B, Samplonius DF, Mueller N, et al
    Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists.
    Cancer Res. 2008;68:597-604.
    PubMed     Related articles    Abstract available
    
    
    
13. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available
    
    
    December 2007
14. SHU ST , Nadella MV, Dirksen WP, Fernandez SA, et al
    A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
    Cancer Res. 2007;67:11859-66.
    PubMed     Related articles    Abstract available
    
    
    
15. DOUBROVIN MM , Doubrovina ES, Zanzonico P, Sadelain M, et al
    In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene.
    Cancer Res. 2007;67:11959-69.
    PubMed     Related articles    Abstract available
    
    
    
16. KAWANO T , Ito M, Raina D, Wu Z, et al
    MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.
    Cancer Res. 2007;67:11576-84.
    PubMed     Related articles    Abstract available
    
    
    
17. EBI H , Matsuo K, Sugito N, Suzuki M, et al
    Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.
    Cancer Res. 2007;67:11158-65.
    PubMed     Related articles    Abstract available
    
    
    November 2007
18. SMEDBY KE , Hjalgrim H, Chang ET, Rostgaard K, et al
    Childhood Social Environment and Risk of Non Hodgkin Lymphoma in Adults.
    Cancer Res. 2007;67:11074-11082.
    PubMed     Related articles    Abstract available
    
    
    
19. ZHANG T , Barber A, Sentman CL
    Chimeric NKG2D Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic Pathways.
    Cancer Res. 2007;67:11029-11036.
    PubMed     Related articles    Abstract available
    
    
    
20. UNGERECHTS G , Springfeld C, Frenzke ME, Lampe J, et al
    Lymphoma Chemovirotherapy: CD20-Targeted and Convertase-Armed Measles Virus Can Synergize with Fludarabine.
    Cancer Res. 2007;67:10939-10947.
    PubMed     Related articles    Abstract available
    
    
    
21. PICCALUGA PP , Agostinelli C, Califano A, Carbone A, et al
    Gene Expression Analysis of Angioimmunoblastic Lymphoma Indicates Derivation from T Follicular Helper Cells and Vascular Endothelial Growth Factor Deregulation.
    Cancer Res. 2007;67:10703-10710.
    PubMed     Related articles    Abstract available
    
    
    
22. JULIGER S , Goenaga-Infante H, Lister TA, Fitzgibbon J, et al
    Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.
    Cancer Res. 2007;67:10984-92.
    PubMed     Related articles    Abstract available
    
    
    
23. MACOR P , Tripodo C, Zorzet S, Piovan E, et al
    In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab.
    Cancer Res. 2007;67:10556-10563.
    PubMed     Related articles    Abstract available
    
    
    October 2007
24. RIDER DA , Havenith CE, de Ridder R, Schuurman J, et al
    A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent fc-dependent effector activity.
    Cancer Res. 2007;67:9945-53.
    PubMed     Related articles    Abstract available
    
    
    
25. SAMPSON VB , Rong NH, Han J, Yang Q, et al
    MicroRNA Let-7a Down-regulates MYC and Reverts MYC-Induced Growth in Burkitt Lymphoma Cells.
    Cancer Res. 2007;67:9762-70.
    PubMed     Related articles    Abstract available
    
    
    September 2007
26. BRADLEY SV , Smith MR, Hyun TS, Lucas PC, et al
    Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
    Cancer Res. 2007;67:8923-31.
    PubMed     Related articles    Abstract available
    
    
    
27. STAVENHAGEN JB , Gorlatov S, Tuaillon N, Rankin CT, et al
    Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Cancer Res. 2007;67:8882-90.
    PubMed     Related articles    Abstract available
    
    
    
28. PIOVAN E , Tosello V, Indraccolo S, Masiero M, et al
    Differential regulation of hypoxia-induced CXCR4 triggering during B-cell development and lymphomagenesis.
    Cancer Res. 2007;67:8605-14.
    PubMed     Related articles    Abstract available
    
    
    
29. PAMIDI A , Cardoso R, Hakem A, Matysiak-Zablocki E, et al
    Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
    Cancer Res. 2007;67:8527-35.
    PubMed     Related articles    Abstract available
    
    
    
30. TAYLOR KH , Kramer RS, Davis JW, Guo J, et al
    Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.
    Cancer Res. 2007;67:8511-8.
    PubMed     Related articles    Abstract available
    
    
    
31. CHAMBERS B , Grufman P, Fredriksson V, Andersson K, et al
    Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
    Cancer Res. 2007;67:8450-5.
    PubMed     Related articles    Abstract available
    
    
    
32. VAN DE WETERING CI , Knudson CM
    Chromosomal instability and supernumerary centrosomes represent precursor defects in a mouse model of T-cell lymphoma.
    Cancer Res. 2007;67:8081-8.
    PubMed     Related articles    Abstract available
    
    
    August 2007
33. GIULIANI N , Morandi F, Tagliaferri S, Lazzaretti M, et al
    Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
    Cancer Res. 2007;67:7665-74.
    PubMed     Related articles    Abstract available
    
    
    
34. HONG X , Lei L, Kunert B, Naredla R, et al
    Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors.
    Cancer Res. 2007;67:7165-74.
    PubMed     Related articles    Abstract available
    
    
    
35. BALASENTHIL S , Gururaj AE, Talukder AH, Bagheri-Yarmand R, et al
    Identification of Pax5 as a target of MTA1 in B-cell lymphomas.
    Cancer Res. 2007;67:7132-8.
    PubMed     Related articles    Abstract available
    
    
    
36. BAGHERI-YARMAND R , Balasenthil S, Gururaj AE, Talukder AH, et al
    Metastasis-associated protein 1 transgenic mice: a new model of spontaneous B-cell lymphomas.
    Cancer Res. 2007;67:7062-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
37. LIU A , Guardino A, Chinsangaram L, Goldstein MJ, et al
    Therapeutic Vaccination against Murine Lymphoma by Intratumoral Injection of Recombinant Fowlpox Virus Encoding CD40 Ligand.
    Cancer Res. 2007;67:7037-44.
    PubMed     Related articles    Abstract available
    
    
    
38. POPOV SW , Moldenhauer G, Wotschke B, Bruderlein S, et al
    Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Cancer Res. 2007;67:6555-64.
    PubMed     Related articles    Abstract available
    
    
    
39. POCHAMPALLI MR , Bitler BG, Schroeder JA
    Transforming growth factor alpha dependent cancer progression is modulated by Muc1.
    Cancer Res. 2007;67:6591-8.
    PubMed     Related articles    Abstract available
    
    
    
40. VALENZUELA HF , Pace KE, Cabrera PV, White R, et al
    O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
    Cancer Res. 2007;67:6155-62.
    PubMed     Related articles    Abstract available
    
    
    June 2007
41. FERNBERG P , Odenbro A, Bellocco R, Boffetta P, et al
    Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in sweden.
    Cancer Res. 2007;67:5983-6.
    PubMed     Related articles    Abstract available
    
    
    
42. PAGEL JM , Pantelias A, Hedin N, Wilbur S, et al
    Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.
    Cancer Res. 2007;67:5921-8.
    PubMed     Related articles    Abstract available
    
    
    
43. ENGEL LS , Laden F, Andersen A, Strickland PT, et al
    Polychlorinated Biphenyl Levels in Peripheral Blood and Non-Hodgkin's Lymphoma: A Report from Three Cohorts.
    Cancer Res. 2007;67:5545-52.
    PubMed     Related articles    Abstract available
    
    
    
44. GOMEZ-BOUGIE P , Wuilleme-Toumi S, Menoret E, Trichet V, et al
    Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Cancer Res. 2007;67:5418-24.
    PubMed     Related articles    Abstract available
    
    
    
45. DE MILITO A , Iessi E, Logozzi M, Lozupone F, et al
    Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
    Cancer Res. 2007;67:5408-17.
    PubMed     Related articles    Abstract available
    
    
    
46. TATETSU H , Ueno S, Hata H, Yamada Y, et al
    Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.
    Cancer Res. 2007;67:5328-36.
    PubMed     Related articles    Abstract available
    
    
    
47. STEWART M , Mackay N, Hanlon L, Blyth K, et al
    Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas.
    Cancer Res. 2007;67:5126-33.
    PubMed     Related articles    Abstract available
    
    
    
48. VILLA-MORALES M , Santos J, Perez-Gomez E, Quintanilla M, et al
    A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas.
    Cancer Res. 2007;67:5107-16.
    PubMed     Related articles    Abstract available
    
    
    May 2007
49. LIM U , Gayles T, Katki HA, Stolzenberg-Solomon R, et al
    Serum High-Density Lipoprotein Cholesterol and Risk of Non-Hodgkin Lymphoma.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
50. WANG SS , Cozen W, Cerhan JR, Colt JS, et al
    Immune Mechanisms in Non-Hodgkin Lymphoma: Joint Effects of the TNF G308A and IL10 T3575A Polymorphisms with Non-Hodgkin Lymphoma Risk Factors.
    Cancer Res. 2007;67:5042-54.
    PubMed     Related articles    Abstract available
    
    
    
51. VANDERKERKEN K , Medicherla S, Coulton L, De Raeve H, et al
    Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Cancer Res. 2007;67:4572-7.
    PubMed     Related articles    Abstract available
    
    
    
52. VOENA C , Conte C, Ambrogio C, Boeri Erba E, et al
    The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration.
    Cancer Res. 2007;67:4278-86.
    PubMed     Related articles    Abstract available
    
    
    
53. ZHAO X , Mohaupt M, Jiang J, Liu S, et al
    Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
    Cancer Res. 2007;67:4443-50.
    PubMed     Related articles    Abstract available
    
    
    
54. REDDY JA , Dorton R, Westrick E, Dawson A, et al
    Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate.
    Cancer Res. 2007;67:4434-42.
    PubMed     Related articles    Abstract available
    
    
    
55. BOYLAN KL , Gosse MA, Staggs SE, Janz S, et al
    A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
    Cancer Res. 2007;67:4069-78.
    PubMed     Related articles    Abstract available
    
    
    April 2007
56. HUSSAIN AR , Al-Jomah NA, Siraj AK, Manogaran P, et al
    Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells.
    Cancer Res. 2007;67:3888-3897.
    PubMed     Related articles    Abstract available
    
    
    
57. BARTHOLOMEUSZ G , Talpaz M, Bornmann W, Kong LY, et al
    Degrasyn activates proteasomal-dependent degradation of c-Myc.
    Cancer Res. 2007;67:3912-8.
    PubMed     Related articles    Abstract available
    
    
    
58. CARLO-STELLA C , Guidetti A, Di Nicola M, Lavazza C, et al
    IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
    Cancer Res. 2007;67:3269-75.
    PubMed     Related articles    Abstract available
    
    
    
59. CHNG WJ , Kumar S, Vanwier S, Ahmann G, et al
    Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
    Cancer Res. 2007;67:2982-9.
    PubMed     Related articles    Abstract available
    
    
    March 2007
60. DEMERS M , Biron-Pain K, Hebert J, Lamarre A, et al
    Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
    Cancer Res. 2007;67:2824-9.
    PubMed     Related articles    Abstract available
    
    
    
61. STRAUSS SJ , Higginbottom K, Juliger S, Maharaj L, et al
    The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines.
    Cancer Res. 2007;67:2783-90.
    PubMed     Related articles    Abstract available
    
    
    
62. SINGH H , Serrano LM, Pfeiffer T, Olivares S, et al
    Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.
    Cancer Res. 2007;67:2872-80.
    PubMed     Related articles    Abstract available
    
    
    
63. DUQUETTE ML , Huber MD, Maizels N
    G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas.
    Cancer Res. 2007;67:2586-94.
    PubMed     Related articles    Abstract available
    
    
    
64. QI CF , Zhou JX, Lee CH, Naghashfar Z, et al
    Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Cancer Res. 2007;67:2439-47.
    PubMed     Related articles    Abstract available
    
    
    
65. HJALGRIM H , Ekstrom Smedby K, Rostgaard K, Molin D, et al
    Infectious mononucleosis, childhood social environment, and risk of hodgkin lymphoma.
    Cancer Res. 2007;67:2382-8.
    PubMed     Related articles    Abstract available
    
    
    
66. AIT-TAHAR K , Barnardo MC, Pulford K
    CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma.
    Cancer Res. 2007;67:1898-901.
    PubMed     Related articles    Abstract available
    
    
    February 2007
67. BROOKES PS , Morse K, Ray D, Tompkins A, et al
    The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore.
    Cancer Res. 2007;67:1793-802.
    PubMed     Related articles    Abstract available
    
    
    
68. MEISTER S , Schubert U, Neubert K, Herrmann K, et al
    Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Cancer Res. 2007;67:1783-92.
    PubMed     Related articles    Abstract available
    
    
    
69. PODAR K , Raab MS, Tonon G, Sattler M, et al
    Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.
    Cancer Res. 2007;67:1680-8.
    PubMed     Related articles    Abstract available
    
    
    
70. DU Y , Honeychurch J, Glennie M, Johnson P, et al
    Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
    Cancer Res. 2007;67:1335-43.
    PubMed     Related articles    Abstract available
    
    
    
71. JAZIREHI AR , Vega MI, Bonavida B
    Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
    Cancer Res. 2007;67:1270-81.
    PubMed     Related articles    Abstract available
    
    
    
72. LEPELLETIER Y , Camara-Clayette V, Jin H, Hermant A, et al
    Prevention of Mantle Lymphoma Tumor Establishment by Routing Transferrin Receptor toward Lysosomal Compartments.
    Cancer Res. 2007;67:1145-54.
    PubMed     Related articles    Abstract available
    
    
    
73. CHEN A , Liu S, Park D, Kang Y, et al
    Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer.
    Cancer Res. 2007;67:1291-8.
    PubMed     Related articles    Abstract available
    
    
    
74. SEKIMOTO E , Ozaki S, Ohshima T, Shibata H, et al
    A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
    Cancer Res. 2007;67:1184-92.
    PubMed     Related articles    Abstract available
    
    
    
75. YOSHIO-HOSHINO N , Adachi Y, Aoki C, Pereboev A, et al
    Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor.
    Cancer Res. 2007;67:871-5.
    PubMed     Related articles    Abstract available
    
    
    January 2007
76. VERHELLE D , Corral LG, Wong K, Mueller JH, et al
    Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells.
    Cancer Res. 2007;67:746-55.
    PubMed     Related articles    Abstract available
    
    
    
77. EICHENAUER DA , Simhadri VL, von Strandmann EP, Ludwig A, et al
    ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.
    Cancer Res. 2007;67:332-8.
    PubMed     Related articles    Abstract available
    
    
    
78. HEATH DJ , Vanderkerken K, Cheng X, Gallagher O, et al
    An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Cancer Res. 2007;67:202-8.
    PubMed     Related articles    Abstract available
    
    
    December 2006
79. CHEN D , Chan R, Waxman S, Jing Y, et al
    Buthionine Sulfoximine Enhancement of Arsenic Trioxide-Induced Apoptosis in Leukemia and Lymphoma Cells Is Mediated via Activation of c-Jun NH2-Terminal Kinase and Up-regulation of Death Receptors.
    Cancer Res. 2006;66:11416-23.
    PubMed     Related articles    Abstract available
    
    
    
80. FUJITA K , Tsujimura A, Miyagawa Y, Kiuchi H, et al
    Isolation of Germ Cells from Leukemia and Lymphoma Cells in a Human In vitro Model: Potential Clinical Application for Restoring Human Fertility after Anticancer Therapy.
    Cancer Res. 2006;66:11166-71.
    PubMed     Related articles    Abstract available
    
    
    
81. RUBINSTEIN DB , Karmely M, Ziv R, Benhar I, et al
    MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Cancer Res. 2006;66:11247-53.
    PubMed     Related articles    Abstract available
    
    
    November 2006
82. BUCK AK , Bommer M, Stilgenbauer S, Juweid M, et al
    Molecular Imaging of Proliferation in Malignant Lymphoma.
    Cancer Res. 2006;66:11055-11061.
    PubMed     Related articles    Abstract available
    
    
    
83. KOWOLIK CM , Topp MS, Gonzalez S, Pfeiffer T, et al
    CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Cancer Res. 2006;66:10995-1004.
    PubMed     Related articles    Abstract available
    
    
    
84. LI Z , Mahesh SP, Shen de F, Liu B, et al
    Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.
    Cancer Res. 2006;66:10586-93.
    PubMed     Related articles    Abstract available
    
    
    
85. MARTIN-SUBERO JI , Klapper W, Sotnikova A, Callet-Bauchu E, et al
    Chromosomal breakpoints affecting immunoglobulin Loci are recurrent in hodgkin and reed-sternberg cells of classical hodgkin lymphoma.
    Cancer Res. 2006;66:10332-8.
    PubMed     Related articles    Abstract available
    
    
    October 2006
86. YANG ZZ , Novak AJ, Ziesmer SC, Witzig TE, et al
    Attenuation of CD8+ T-Cell Function by CD4+CD25+ Regulatory T Cells in B-Cell Non-Hodgkin's Lymphoma.
    Cancer Res. 2006;66:10145-52.
    PubMed     Related articles    Abstract available
    
    
    
87. WANG SS , Cerhan JR, Hartge P, Davis S, et al
    Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma.
    Cancer Res. 2006;66:9771-80.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    September 2006
88. KENDALL HE , Vacek PM, Rivers JL, Rice SC, et al
    Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.
    Cancer Res. 2006;66:8455-61.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    August 2006
89. ZHANG M , Yao Z, Zhang Z, Garmestani K, et al
    The Anti-CD25 Monoclonal Antibody 7G7/B6, Armed with the {alpha}-Emitter 211At, Provides Effective Radioimmunotherapy for a Murine Model of Leukemia.
    Cancer Res. 2006;66:8227-32.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
90. BAUGHN LB , Di Liberto M, Wu K, Toogood PL, et al
    A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.
    Cancer Res. 2006;66:7661-7.
    PubMed     Related articles    Abstract available
    
    
    
91. WENDEL HG , Malina A, Zhao Z, Zender L, et al
    Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo.
    Cancer Res. 2006;66:7639-46.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: